| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), LGND's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $46.37M | - | |
| Dir | 43.7K | $12.56M | - | |
| CFO | 28.6K | $8.21M | - | |
| Dir | 11.7K | $3.35M | - | |
| Dir | 4.4K | $1.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2015 | Herman Melanie J | Director Of Accounting | Sell | 510 | $57.84 | $29,498.40 | -12.7% | |
| Feb 10, 2015 | Desilva Nishan M | VP, Corporate Development | Sell | 2,300 | $56.34 | $129,582.00 | -12.3% |